title: Monitor unit optimization in RapidArc plans for prostate cancer.
abstract: Intensity-modulated radiation therapy (IMRT) has become a standard treatment for prostate cancer based on the superior sparing of the bladder, rectum, and other surrounding normal tissues compared to three-dimensional conformal radiotherapy, despite the longer delivery time and the increased number of monitor units (MU). The novel RapidArc technique represents a further step forward because of the lower number of MUs per fraction and the shorter delivery time, compared to IMRT. This paper refers to MU optimization in RA plans for prostate cancer, using a tool incorporated in Varian TPS Eclipse. The goal was to get the lowest MU RA plan for each patient, keeping a well-defined level of PTV coverage and OAR sparing. Seven prostate RA plans (RA MU-Optimized) were retrospectively generated using the MU optimization tool in Varian Eclipse TPS. Dosimetric outcome and nontarget tissue sparing were, compared to those of RA clinical plans (RA Clinical) used to treat patients. Compared to RA Clinical, RA MU-Optimized plans resulted in an about 28% (p = 0.018) reduction in MU. The total integral dose (ID) to each nontarget tissue (but not the penile bulb) showed a consistent average relative reduction, statistically significant only for the femoral heads. Within the intermediate dose region (40-60 Gy), ID reductions (4%-17% p &lt; 0.05) were found for the rectum, while a slight but significant (0.4%-0.9%, p &lt; 0.05) higher ID was found for the whole body. Among the remaining data, the mean dose to the bladder was also reduced (-12%, p = 0.028). Plans using MU optimization are clinically applicable and more MU efficient, ameliorating the exposure of the rectum and the bladder to intermediate doses.
authors: Medical Physics, IRCCS CROB, Rionero in Vulture, PZ, Italy . clemente_stefania@libero.it
authors: Stefania
authors: S
authors: Clemente
authors: Mariella
authors: M
authors: Cozzolino
authors: Costanza
authors: C
authors: Chiumento
authors: Alba
authors: A
authors: Fiorentino
authors: Rocchina
authors: R
authors: Caivano
authors: Vincenzo
authors: V
authors: Fusco
mesh_terms: D015331:Cohort Studies; D006801:Humans; D008297:Male; D059351:Organ Sparing Treatments / Q000379:methods*; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D050397:Radiotherapy, Intensity-Modulated
references: Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1195-203
references: 15990025
references: Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1510-5
references: 15817357
references: Radiother Oncol. 1986 Mar;5(3):215-21
references: 3085170
references: Radiother Oncol. 2002 Jun;63(3):249-55
references: 12142088
references: Clin Oncol (R Coll Radiol). 2009 Nov;21(9):706-12
references: 19713087
references: Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):434-42
references: 12023148
references: Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):667-72
references: 9231693
references: Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):83-8
references: 12694826
references: Radiother Oncol. 2003 Jul;68(1):1-14
references: 12885446
references: Lancet Oncol. 2007 Jun;8(6):475-87
references: 17482880
references: Acta Oncol. 2009;48(2):227-32
references: 18855157
references: Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1550-8
references: 21543164
references: Int J Radiat Oncol Biol Phys. 1999 Nov 1;45(4):951-61
references: 10571202
references: Med Phys. 2011 Nov;38(11):5844-56
references: 22047348
references: Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):251-5
references: 9607337
references: Radiat Oncol. 2011 Feb 22;6:21
references: 21342509
references: Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):935-42
references: 20044214
references: Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):996-1001
references: 18455326
references: Cancer. 2000 Jan 15;88(2):398-406
references: 10640974
references: Med Phys. 2008 Jan;35(1):310-7
references: 18293586
references: J Natl Cancer Inst. 1985 May;74(5):955-75
references: 3858584
references: Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):147-54
references: 14697432
references: Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):880-914
references: 11704310
references: Med Phys. 1998 May;25(5):656-61
references: 9608475
references: Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):962-7
references: 16458781
references: Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1371-80
references: 11121636
references: Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):920-6
references: 20675077
references: Radiother Oncol. 2008 Nov;89(2):180-91
references: 18692929
references: Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):953-9
references: 22172904
references: Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1248-55
references: 20947268
references: Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):1-7
references: 16618572
references: Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1135-44
references: 17208388
references: J Urol. 2005 May;173(5):1526-9
references: 15821472